TWTianlun Wang

Tianlun Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tianlun Wang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Aoshuang Li

    Affiliated Dongtai Hospital of Nantong University, Nantong 224200, P. R. China

    1 shared publication
  • Fei Song

    Department of Hepatobiliary Surgery & Liver Transplantation, Liver Cancer Institute, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Zhongshan Hospital Fudan University, Shanghai, China

    1 shared publication
  • Hanchuan Tao

    Department of General Surgery, Affiliated Dongtai Hospital of Nantong University, Yancheng, China

    1 shared publication
  • Jie Xu

    Department of Hepatobiliary Surgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226007, P. R. China

    1 shared publication
  • Jinju Shen

    Yixing People’s Hospital, Yixing 214222, P. R. China

    1 shared publication
  • Yu Wang

    Department of Hepatobiliary Surgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226007, P. R. China

    1 shared publication

Latest Publications

  • Highly Pifithrin-μ Loaded Melanin Nanosphere: A Safe and Efficient Approach to Hepatocellular Carcinoma Therapy via Thermo-Controlled Drug Release

    by Yu Wang, Jie Xu, Fei Song, Hanchuan Tao, Tianlun Wang, Jinju Shen, Aoshuang Li, Zhong Chen

    Pifithrin-[ ], a potent dual-pathway inhibitor of p53 and HSP70, suffers from poor aqueous solubility and dose-limiting systemic toxicity, which severely hinder its anticancer efficacy. To overcome these limitations, we developed melanin-based nanospheres (MNSs) through alkaline-driven self-polymerization of dopamine. Capitalizing on [ ]–[ ] stacking interactions, we achieved efficient surface loading of pifithrin-[ ] (forming MNS-[ ] with a high drug-loading capacity of 40%. The resulting MNS-[ ] platform exhibited excellent colloidal stability under simulated physiological conditions and displayed sustained, thermoresponsive drug release kinetics, retaining [ ] of the payload at physiological temperature while triggering rapid release at [ ]C. Flow cytometry and confocal microscopy analyzes confirmed enhanced cellular internalization of MNS-[ ] in HepG2 cells. Upon laser irradiation, MNS-[ ] mediated localized photothermal effects, enabling spatiotemporally controlled drug release and significant cytotoxicity, reducing HepG2 cell viability to 35% at 200[ ][ ]g/mL. In contrast, PEGylated MNS (MNS-PEG) controls showed negligible photothermal toxicity. In a HepG2 xenograft mouse model, the combination of MNS-[ ] and near-infrared (NIR) irradiation achieved superior tumor growth inhibition ([ ] reduction in tumor volume) compared to free pifithrin-[ ] monotherapy, attributable to enhanced tumor accumulation and on-demand drug release. Histopathological examination revealed extensive tumor necrosis in the combination group without observed systemic toxicity. This study highlights MNSs as a versatile and biocompatible nanoplatform for enhancing the therapeutic index of hydrophobic agents via photothermally augmented targeting and stimuli-responsive delivery.